Letters To The Editor


Author and Disclosure Information



To the Editor: The article “ Dabigatran: Will it change clinical practice 1 has a dangerous error. In its Key Points, it says “dabigatran is a potent, reversible direct thrombin inhibitor.” In fact, it is not reversible. 2

Shamefully poor editing.

Next Article:

In reply: Dabigatran

Related Articles